Physician

Efrat Dotan, MD

According to 2025 Medicare claims, Efrat Dotan, MD (NPI: 1740312990) practices hematopoietic cell transplantation and cellular therapy in the Lancaster, PA market, with the plurality of this provider's patient population coming from Lancaster, PA. This provider's primary affiliated billing organization is LANCASTER GENERAL MEDICAL GROUP (NPI: 1376526152; TIN: 232777286) and primary practice location at 17601-2644. Dotan is affiliated with the Lancaster General Health Community Care Collaborative, LLC (ACO ID: A2019), participating under the MSSP model.

Dotan's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 93 traditional Medicare patients, billed 343 HCPCS/CPT codes, and received $31,032 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 225 prescription claims across 58 beneficiaries totaling $312,801 in drug costs, led by Eliquis (Apixaban). 2023 DME data shows 25 claims. Open Payments data shows 15 records totaling $63,744. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $35,390 and ending at $31,032. Concurrently, Part D prescription costs have risen steadily, from $28,488 to $312,801. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.